MENU
ARDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ardelyx (ARDX) Earnings Date & Reports

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ARDX is expected to report earnings to rise ∞% to 0 cents per share on March 11

Ardelyx ARDX Stock Earnings Reports
Q4'25
Est.
$0.01
Q3'25
Beat
by $0.06
Q2'25
Beat
by $0.05
Q1'25
Missed
by $0.06
Q4'24
Beat
by $0.01
The last earnings report on October 30 showed earnings per share of 0 cents, beating the estimate of -5 cents. With 809.75K shares outstanding, the current market capitalization sits at 1.47B.
View a ticker or compare two or three
ARDX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ARDX showed earnings on October 30, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
400 Fifth Avenue
Phone
+1 510 745-1700
Employees
267
Web
https://www.ardelyx.com